Abstract
After heart surgery there may be many hours in which cardiac output is reversibly depressed. Treatment is given to enhance output and to ensure an adequate blood supply to vital organs. Drugs used in this situation commonly include dopamine and dobutamine. Dopexamine (Dopacard-Speywood) is a dopamine analogue which in the UK is licensed only for the short-term treatment of patients with low cardiac output after heart surgery. The manufacturer claims that dopexamine is particularly effective in promoting renal and splanchnic blood flow. Is dopexamine an advance on dopamine and dobutamine?
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
